StockWatch
·

Wakefit Innovations Ltd Q1 FY27 Results

WAKEFITQ1 FY27 Results
Filing
Result:Good· Market: FlatMargin expansionCost led

Outlook: Optimistic · Guidance: Maintained

MetricValuevs Q4 FY26
Revenue404.91 Cr17.8%
Total Income420.53 Cr16.5%
Expenditure384.23 Cr13.8%
PBT36.30 Cr53.4%
Net Profit23.38 Cr80.8%
OPM13.93%3.26pp
NPM5.56%28.17pp
EPS0.7180.8%
View full financials

Revenue +16.7% YoY with EBITDA margin expanding ~260bps (15.2%→17.8%) on a clean, one-off-free quarter is solidly above-average, though PAT growth (+19.2%) is muted only by tax normalization (not a core-business issue) and revenue trails management's own 20%+ FY27 guidance, keeping it short of a standout.

WAKEFIT · Q1 FY27 · THE VERDICT

Mattress Momentum Meets Guidance Risk

Strong mattress volume (27.3% growth) and store expansion deliver solid Q1 execution, but revenue growth of 16.6% falls short of the 20%+ FY27 guidance. Management's silence on re-commitment signals caution ahead.

14 Aug 2026 · 6 min read
Reported PAT

₹23.4 Cr

+19.2% YoY

Deferred tax effect

-₹7.3 Cr

vs +₹98 Cr prior Q

Operating PAT

₹30.7 Cr

7.6% NPM · organic number

Profit took a tax hit. Q1 reported PAT of ₹23.4 crore includes a ₹7.3 crore deferred tax charge — a swing from the ₹98 crore tax benefit in the prior quarter. Strip that out: underlying operating profit is ₹30.7 crore, a 7.6% net margin. That's the organic takeaway.

The real story: revenue trajectory

But the profit math isn't the headline risk. It's this: Q1 revenue of ₹404.9 crore grew 16.6% year-on-year. That's solid momentum. It's not what Wakefit promised. In the prior year's guidance, management said it was targeting at least 20% revenue growth for FY27, driven by mattress and improving reach in furniture and furnishings. Q1 landed at 16.6%. For a full-year hit of 20%+, H2 would need to accelerate sharply. Management declined to re-commit to the target on this call, saying they weren't in a position to comment yet. That silence is a caution signal.

What the quarter actually delivered

Mattress — 65.9% of revenue — delivered 27.3% year-on-year growth: 2/3 volume-driven, 1/3 from pricing. Volume momentum came from 27 COCO store additions (tracking toward 80 for the year), positive same-store same-group sales, and strong online marketplace uptake. Pricing gains came from two 5% price increases, necessary to offset raw material cost inflation (polyol and TDI spot prices up 70–160% from Middle East supply shocks). Management achieved a net pass-through of roughly 30–40% inflation via supplier relationships and passed the rest to customers.

Furniture — 28% of revenue — decelerated from prior growth rates. Management consciously paused furniture-first store openings to improve unit economics and cited machine breakdowns and workforce shortages. Growth is expected to return to mid-teens in the next two quarters, then step-jump to 25–30% post-Jumbo store launch (June–July 2027). Furnishing and Decor (6.3% of revenue) held steady.

Own channels — COCO stores plus direct-to-consumer website — held 72.3% of revenue and grew 20.5% year-on-year. Online was 52.7% of total revenue; offline 47.3%. External channels (marketplaces) recovered to 7.6% growth after two quarters of sharp 15–20% declines, powered by marketplace partners' focus on growth cycles and major sale events (notably July).

The margin buffer is depleting

Gross margin of 57.1% was up 190 basis points from 55.8% a year ago — a standout number given raw material headwinds. The company achieved it via two levers: first, pricing pass-throughs (5% twice), and second, inventory rundown. Q1 held 3–4 weeks of old-cost inventory. That buffer is running out. Management has guided that H1 FY27 will see full raw material cost impact, with gross margin compression of 100–120 basis points. Q2 will be materially worse than Q1.

Management's claims vs. what holds up
Claim on the callReported metricVerdict
Revenue grew 16.6% YoY to ₹404.9 Cr₹404.9 Cr, 16.6% growth confirmedSupported
Mattress 27.3% growth, 2/3 volume 1/3 priceSegment and mix trackSupported
Gross margin +190 bps YoY despite inflation57.1% vs 55.8%; +190 bpsSupported
FY27 at least 20% revenue growthQ1 at 16.6%; full-year pace needed for 20%Overstated (Q1 below trajectory)
H1 margin compression 100–120 bps expected3–4 weeks old-cost inventory, new costs flowing Q2Supported

What changed on this call

Strategic shifts and reversals
  • Mattress momentum re-accelerated (27.3% growth, 2/3 volume)

  • Furniture decelerated; management paused furniture-first stores consciously

  • Raw material headwinds passed partially to customers (5% price hikes twice)

  • External channels recovering after 2 quarters of 15–20% declines

  • Store expansion on track (27 of ~80 FY27 target)

The street's reading

The stock opened to a flat result reaction (day 1: −0.11%), but the verdict faded fast. By day 5, the sell-off had widened to −4.32% — a market-level judgment that the quarter undershot expectations. The stock now trades at ₹121.38, down 45.81% from its all-time high of ₹224. It sits below its 20-day and 50-day moving averages. Institutions are trimming: FII ownership fell 90 basis points quarter-on-quarter to 14.48%, and DII dropped 77 basis points to 25.85%.

The post-result weakness mirrors the fundamental concern: Q1 growth of 16.6% is not a confidence signal for hitting 20%+ full-year. Management's refusal to re-commit adds to the uncertainty. The chart is no longer offering the benefit of the doubt.

Risks, ranked by how much they should concern a holder

Revenue growth trajectory misses FY27 guidance

High

Q1 at 16.6% vs 20%+ target implies full-year below guidance unless H2 accelerates sharply. Management not re-committing signals internal caution.

H1 margin compression capping profit growth

High

100–120 bps of gross margin compression expected in H1 (Q2–Q3) as new-cost inventory flows through. Profit growth will lag revenue growth despite volume momentum.

Jumbo store execution risk

Medium

First store targeted June–July 2027; second Aug–Sept 2027. Delay or underperformance would derail furniture reacceleration and FY28 margin expansion targets.

Furniture category deceleration persists

Medium

Furniture is 28% of revenue but slowest-growing segment (paused for unit economics). Dependent on Jumbo success to re-accelerate; if delayed, blended growth stays below 20% longer.

Raw material volatility

Medium

Polyol/TDI spot prices remain unstable (70–160% inflation). Further escalation could exceed 100–120 bps compression guidance; supply disruptions possible.

What to watch next
  • 1 · Q2 revenue growth trajectory

    Does H2 accelerate toward 20%+ pace, or does full-year guidance get cut? This is the make-or-break question for FY27. Management punted on re-committing; Q2 results will clarify whether that caution was warranted.

  • 2 · Margin compression in Q2

    Does the 100–120 bps H1 compression materialize, or does management hold margins via cost cuts or higher pricing? If compression is worse than guided, profit growth will disappoint despite steady revenue.

  • 3 · Jumbo store construction and June–July 2027 launch

    Excavation nearly complete; civil work ongoing. Any delays signal execution risk. Launch on-time would be a confidence builder for furniture recovery and FY28 margin targets.

Wakefit delivered a solid Q1 on mattress volume momentum (27.3% growth, two-thirds volume) and store expansion (27 COCO stores added). Gross margin resilience (+190 bps despite raw material inflation) demonstrates operational discipline. But the quarter is overshadowed by one critical fact: revenue growth of 16.6% falls short of the 20%+ FY27 guidance that management reiterated a year ago. At this pace, full-year will miss the target. Management's refusal to re-commit signals they know it too.

Profit growth is real but will be capped by near-term margin compression (100–120 basis points in H1) as old-cost inventory depletes and new-cost purchases flow through. The long-term story — Jumbo stores, furniture reacceleration, 16–17% EBITDA margin expansion — is credible, but it's 11+ months away and depends on flawless execution.

This is a steady-quarter-with-near-term-headwinds story, not a step-change. The number to track from here is Q2 revenue growth. If it re-accelerates toward the 20%+ target, the guidance miss fades and the stock can re-rate. If it stays in the 16–18% range, expect further disappointment and cuts. Hold until that clarity emerges.

Informational and educational content only. Not investment advice.

Wakefit Innovations Ltd (WAKEFIT) Q1 FY27 Results, Transcript & Analysis — StockWatch